Alcon AG (ALC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Alcon AG (ALC) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF661.33 Million ≈ $836.10 Million USD) by net assets (CHF22.02 Billion ≈ $27.84 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALC equity financing ratio to measure how much of total assets are equity-financed.
Alcon AG - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Alcon AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Alcon AG (ALC) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Alcon AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alcon AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Telefonaktiebolaget LM Ericsson (publ)
F:ERCA
|
0.077x |
|
STMicroelectronics NV ADR
NYSE:STM
|
0.029x |
|
Baidu Inc
MX:BIDUN
|
0.009x |
|
Ameren Corp
NYSE:AEE
|
0.031x |
|
BeiGene, Ltd.
NASDAQ:ONC
|
0.042x |
|
Orsted A/S
CO:ORSTED
|
0.074x |
|
Prudential plc
F:PRU2
|
0.030x |
|
Cheniere Energy Partners LP
NYSE:CQP
|
11.667x |
Annual Cash Flow Conversion Efficiency for Alcon AG (2015–2025)
The table below shows the annual cash flow conversion efficiency of Alcon AG from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Alcon AG worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF22.02 Billion ≈ $27.84 Billion |
CHF2.38 Billion ≈ $3.01 Billion |
0.108x | +12.11% |
| 2024-12-31 | CHF21.55 Billion ≈ $27.25 Billion |
CHF2.08 Billion ≈ $2.63 Billion |
0.096x | +43.19% |
| 2023-12-31 | CHF20.62 Billion ≈ $26.07 Billion |
CHF1.39 Billion ≈ $1.75 Billion |
0.067x | +8.81% |
| 2022-12-31 | CHF19.68 Billion ≈ $24.88 Billion |
CHF1.22 Billion ≈ $1.54 Billion |
0.062x | -11.45% |
| 2021-12-31 | CHF19.26 Billion ≈ $24.34 Billion |
CHF1.34 Billion ≈ $1.70 Billion |
0.070x | +59.74% |
| 2020-12-31 | CHF18.82 Billion ≈ $23.80 Billion |
CHF823.00 Million ≈ $1.04 Billion |
0.044x | -8.26% |
| 2019-12-31 | CHF19.30 Billion ≈ $24.40 Billion |
CHF920.00 Million ≈ $1.16 Billion |
0.048x | -18.41% |
| 2018-12-31 | CHF19.52 Billion ≈ $24.67 Billion |
CHF1.14 Billion ≈ $1.44 Billion |
0.058x | +10.45% |
| 2017-12-31 | CHF23.03 Billion ≈ $29.11 Billion |
CHF1.22 Billion ≈ $1.54 Billion |
0.053x | -2.24% |
| 2016-12-31 | CHF23.01 Billion ≈ $29.09 Billion |
CHF1.25 Billion ≈ $1.57 Billion |
0.054x | -6.66% |
| 2015-12-31 | CHF23.64 Billion ≈ $29.88 Billion |
CHF1.37 Billion ≈ $1.73 Billion |
0.058x | -- |
About Alcon AG
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other product… Read more